SCHEMBL7401871

SCHEMBL7401871

CCCC(=O)Oc1ccc(N(C)C)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL9 O00512 1/20 0.57
▸ CTNNB1 P35222 1/20 0.57
▸ KMT2A Q03164 9/20 0.52
▸ MAPT P10636 8/20 0.52
▸ ALDH1A1 P00352 7/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ ESR1 P03372 2/20 0.46
▸ RAB9A P51151 5/20 0.45
▸ KDM4E B2RXH2 4/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ MCL1 Q07820 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ HDAC1 Q13547 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10882811 0.90 ALDH1A1 (0.50) BCL9CTNNB1KMT2AMAPTALDH1A1
SCHEMBL29126681 0.88 BCL9 (0.55) BCL9CTNNB1KMT2AMAPTALDH1A1
SCHEMBL11023644 0.87 BCL9 (0.70) BCL9CTNNB1KMT2AMAPTALDH1A1
SCHEMBL10621983 0.85 KMT2A (0.59) KMT2AMAPTALDH1A1HSD17B10LMNA
SCHEMBL27474678 0.85 SRD5A1 (0.53) BCL9CTNNB1KMT2AMAPTALDH1A1
SCHEMBL28565371 0.81 KMT2A (0.47) BCL9CTNNB1KMT2AMAPTALDH1A1
SCHEMBL6836918 0.81 BCL9 (0.64) BCL9CTNNB1KMT2AMAPTALDH1A1
SCHEMBL27836538 0.80 MAPT (0.45) KMT2AMAPTALDH1A1HSD17B10LMNA
SCHEMBL8765721 0.79 BCL9 (0.62) BCL9CTNNB1KMT2AMAPTALDH1A1
SCHEMBL2292825 0.79 BCL9 (0.62) BCL9CTNNB1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102129172-B The method of negative resist composition and formation pattern SHIN-ETSU CHEMICAL INDUSTRY CO., LTD. (JP) 2015-09-09 — — CN disclosed
CN-102321212-B Polymkeric substance, chemical-amplification positive anti-corrosion agent composition and pattern formation method SHIN-ETSU CHEMICAL INDUSTRY CO., LTD. (JP) 2015-08-19 — — CN disclosed
CN-102221783-B Chemically amplified positive resist composition and pattern forming process SHINETSU CHEMICAL CO 2015-01-28 — — CN disclosed
CN-102321212-A Polymer, chemically amplified positive resist composition and pattern forming process SHINETSU CHEMICAL CO 2012-01-18 — — CN disclosed
CN-102221783-A Chemically amplified positive resist composition and pattern forming process SHINETSU CHEMICAL CO 2011-10-19 — — CN disclosed
CN-102129172-A Negative resist composition and patterning process SHINETSU CHEMICAL CO 2011-07-20 — — CN disclosed
US-5977118-A 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions and methods of use thereof SANOFI (FR) 1999-11-02 — — US disclosed
EP-0813527-A4 6-SUBSTITUTED PYRAZOLO 3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP INC (US) 1998-09-09 — — EP disclosed
EP-0813527-A1 6-SUBSTITUTED PYRAZOLO 3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI PHARMACEUTICALS, INC. (US) 1997-12-29 — — EP disclosed
US-5656629-A CYCLIC GUANOSINE MONOPHSPHATE-PHOSPHODIESTERASE INHIBITOR; USEFUL FOR TREATING HEART FAILURE AND/OR HYPERTENSION SANOFI WINTHROP, INC. (US) 1997-08-12 — — US disclosed
WO-1996028429-A1 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 — — WO disclosed
Send feedback